BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25991099)

  • 1. Participatory design for drug-drug interaction alerts.
    Luna D; Otero C; Almerares A; Stanziola E; Risk M; González Bernaldo de Quirós F
    Stud Health Technol Inform; 2015; 210():45-9. PubMed ID: 25991099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Participatory Design for Drug-Drug Interaction Alerts. A Comparison Study Between Two Interfaces.
    Luna D; Otero C; Risk M; Stanziola E; González Bernaldo de Quirós F
    Stud Health Technol Inform; 2016; 228():68-72. PubMed ID: 27577343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. User-centered design improves the usability of drug-drug interaction alerts: Experimental comparison of interfaces.
    Luna DR; Rizzato Lede DA; Otero CM; Risk MR; González Bernaldo de Quirós F
    J Biomed Inform; 2017 Feb; 66():204-213. PubMed ID: 28108211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. User-Centered Design Improves the Usability of Drug-Drug Interaction Alerts: A Validation Study in the Real Scenario.
    Luna DR; Rizzato Lede DA; Rubin L; Otero CM; Ortiz JM; García MG; Rapisarda RP; Risk MR; González Bernaldo de Quirós F
    Stud Health Technol Inform; 2017; 245():1085-1089. PubMed ID: 29295269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of alerts for potassium-increasing drug-drug-interactions.
    Eschmann E; Beeler PE; Zünd G; Blaser J
    Stud Health Technol Inform; 2013; 192():1056. PubMed ID: 23920830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of drug-drug interaction alert rules in a pediatric hospital's electronic health record system using a visual analytics dashboard.
    Simpao AF; Ahumada LM; Desai BR; Bonafide CP; Gálvez JA; Rehman MA; Jawad AF; Palma KL; Shelov ED
    J Am Med Inform Assoc; 2015 Mar; 22(2):361-9. PubMed ID: 25318641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a SNOMED CT based national medication decision support system.
    Greibe K
    Stud Health Technol Inform; 2013; 192():1147. PubMed ID: 23920921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interaction alerts in software--what do general practitioners and pharmacists want?
    Yu KH; Sweidan M; Williamson M; Fraser A
    Med J Aust; 2011 Dec; 195(11-12):676-80. PubMed ID: 22171864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four principles for user interface design of computerised clinical decision support systems.
    Kanstrup AM; Christiansen MB; Nøhr C
    Stud Health Technol Inform; 2011; 166():65-73. PubMed ID: 21685612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participatory interaction design in user requirements specification in healthcare.
    Martikainen S; Ikävalko P; Korpela M
    Stud Health Technol Inform; 2010; 160(Pt 1):304-8. PubMed ID: 20841698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicians' decisions to override computerized drug alerts in primary care.
    Weingart SN; Toth M; Sands DZ; Aronson MD; Davis RB; Phillips RS
    Arch Intern Med; 2003 Nov; 163(21):2625-31. PubMed ID: 14638563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical evaluation of clinical decision support for the detection of drug-drug interactions.
    Smithburger PL; Buckley MS; Bejian S; Burenheide K; Kane-Gill SL
    Expert Opin Drug Saf; 2011 Nov; 10(6):871-82. PubMed ID: 21542665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What, if all alerts were specific - estimating the potential impact on drug interaction alert burden.
    Seidling HM; Klein U; Schaier M; Czock D; Theile D; Pruszydlo MG; Kaltschmidt J; Mikus G; Haefeli WE
    Int J Med Inform; 2014 Apr; 83(4):285-91. PubMed ID: 24484781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of a clinical decision rule-based alert system for drug dose adjustment in patients with renal failure intended to improve pharmacists' analysis of medication orders in hospitals.
    Boussadi A; Caruba T; Karras A; Berdot S; Degoulet P; Durieux P; Sabatier B
    Int J Med Inform; 2013 Oct; 82(10):964-72. PubMed ID: 23831104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety features and alerts in electronic patient medication record systems used in community pharmacy in England: an exploratory study.
    Ojeleye O; Avery A; Boyd M
    Stud Health Technol Inform; 2013; 192():1142. PubMed ID: 23920916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Standardized Rating Tool for Drug Alerts to Reduce Information Overload.
    Pfistermeister B; Sedlmayr B; Patapovas A; Suttner G; Tektas O; Tarkhov A; Kornhuber J; Fromm MF; Bürkle T; Prokosch HU; Maas R
    Methods Inf Med; 2016 Dec; 55(6):507-515. PubMed ID: 27782288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative analysis of prescription activity and alert usage in a computerized physician order entry system.
    Wipfli R; Betrancourt M; Guardia A; Lovis C
    Stud Health Technol Inform; 2011; 169():940-4. PubMed ID: 21893884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of Adverse Drug Events-Scorecards.
    Marcilly R; Chazard E; Beuscart-Zéphir MC; Hackl W; Băceanu A; Kushniruk A; Borycki EM
    Stud Health Technol Inform; 2011; 164():377-81. PubMed ID: 21335740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of clinical decision support in pharmacist response to drug-interaction alerts.
    Miller L; Steinmetz Pater K; Corman S
    Res Social Adm Pharm; 2015; 11(3):480-6. PubMed ID: 25636198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of a clinical decision support system for computerized drug prescription entries in a large tertiary care hospital.
    Zenziper Y; Kurnik D; Markovits N; Ziv A; Shamiss A; Halkin H; Loebstein R
    Isr Med Assoc J; 2014 May; 16(5):289-94. PubMed ID: 24979833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.